| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LA16c-306E5.2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | SH2B2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | C5orf52 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | TRMT44 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | RGS13 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | MFSD3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | SNRNP40 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | RP9 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | RC3H2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
